M.I. Tech Co., Ltd. develops and manufactures non-vascular stent system. Its products include HANAROSTENT and CHOOSTENT for esophagus, biliary, duodenum, colon and trachea. The company was founded in April 1, 1991 and is headquartered in Pyeongtaek-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company